New research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...

Learn how GLP-1 receptor agonists show promise in reducing alcohol consumption and aiding weight loss in obesity treatment.

Columnist Jen Cueva talks with her friend Lynda Pinto, who has PH, about Lynda's experience with GLP-1 agonist medications.

Often used as a weight-loss treatment, drugs such as Wegovy and Mounjaro have helped more than 500,000 people shed the extra ...

Glucagon-like peptide 1 receptor agonist treatment is not associated with an increased risk for psychiatric adverse events or worsening depressive symptoms.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

GLP-1 RAs are great medications to help with weight loss and are particularly effective in decreasing “food noise” and the ...

“Our study found a similar incidence of obesity-related cancer among patients treated with first-generation glucagon-like peptide-1 receptor ... do not yet fully understand how GLP-1s work ...